Expert Insights on Osteoporosis
A New York jury awarded $8 million to plaintiff 72-year-old Shirley Boles from Fort Walton, Florida who claimed Merck’s osteoporosis drug Fosamax destroyed her jawbone causing serious pain and disability. The jury concluded that Fosamax was “unreasonably dangerous due to defective design, and that its defective design was a legal cause of Mrs. Boles’ injury.”… Read more
Tobacco products are no longer available for sale to teenagers under the age of 18. Parts of the Tobacco Control Act signed last year at this time by President Obama went into effect this week: No tobacco sales to minors. No packs smaller than 20 cigarettes that were considered soft marketing to teens. Changes in… Read more
On the heels of the European Union’s approval, the FDA announced today approval of Amgen’s osteoporosis drug Prolia™ (denosumab) for treatment of postmenopausal women with osteoporosis. We were expecting news later in the summer, so this early announcement was a surprise. Prolia™ is given in your doctor’s office as a shot under the skin twice… Read more
4BoneHealth was featured in Ranch & Coast Magazine’s June issue. Andrea Naversen, R&C Editor-at-Large, interviewed our Dr. Diane Schneider to learn more about osteoporosis and 4BoneHeath. The article “Make No Bones About It” features questions and answers about bone health. The article is available online at Ranch & Coast’s Website. Learn more about your bones.… Read more
Prolia™ (denosumab), a medicine for treatment of osteoporosis under review by the FDA, received approval today (May 28, 2010) for marketing in the European Union. For Amgen, the maker of Prolia™, this was the drug’s first approval for use. The approval was 2-fold: 1- for treatment of osteoporosis in postmenopausal women at increased risk of fractures… Read more
During my most recent annual physical my physician requested one further blood value to analyze along with the standard blood profile. In addition to the typical lipid panel, CA 125 test, and an array of others, she was also interested in evaluating my vitamin D level. I quietly thought testing my Vitamin D was completely… Read more
Research Article: Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur Dennis M. Black, et al for the Fracture Intervention Trial and HORIZON Pivotal Fracture Trial Steering Committees. New England Journal of Medicine. 2010 May 13;362(19):1761-71. Epub 2010 Mar 24. Background. Bisphosphonates are a class of drugs commonly prescribed for patients who have osteoporosis and… Read more
Welcome to May–National Osteoporosis Awareness and Prevention Month! Unfortunately, few people know that. Osteoporosis is like the red-headed stepchild of health–it gets no respect or attention. Let me give you a high profile example.
One of my favorite tales from childhood made it to the big screen in 3-D no less. The movie, Alice in Wonderland, has brought Lewis Carroll’s vivid writings to life.
Meanwhile, Camilla, Duchess of Cornwall, tried to go down the rabbit hole but only her foot could enter. Rather than making it into the magical world of Wonderland, she ended up with a cast on her left leg.
The current American Academy of Pediatrics recommendation for breast-fed babies is a daily 400 IU supplementation of vitamin D. If babies are receiving one liter or more of formula, no additional supplementation is needed since the formula is fortified with vitamin D.